Actively Recruiting
Use of Physiology to Evaluate Procedural Result After PCI CTO
Led by Isala · Updated on 2025-02-19
200
Participants Needed
2
Research Sites
253 weeks
Total Duration
On this page
Sponsors
I
Isala
Lead Sponsor
A
Abbott
Collaborating Sponsor
AI-Summary
What this Trial Is About
ULTRA-CTO is a prospective multicentre non-randomised investigator-initiated trial designed to enrol 200 subjects with an indication for percutaneous coronary intervention (PCI) of chronic total occluded (CTO) coronary artery. The main objective of the study is to assess the predictive value of post-PCI resting full-cycle ratio (RFR) and fractional flow reserve (FFR) with regard to Fractional flow reserve (SSR) in CTO patients.
CONDITIONS
Official Title
Use of Physiology to Evaluate Procedural Result After PCI CTO
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years and older
- Angiographically successful PCI CTO without any remaining lesion at least 30% proximal to the stented segment
- Ability to perform physiologic measurements and OCT of sufficient quality
- Willingness and capability to provide written informed consent
You will not qualify if you...
- Contraindication for adenosine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Radboud UMC
Nijmegen, Netherlands
Not Yet Recruiting
2
Isala
Zwolle, Netherlands, 8025 AB
Actively Recruiting
Research Team
M
Maarten van Leeuwen, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here